Table 4.
ASCVD prevalence in the HELLAS-FH registry stratified by T2DM status.
| Prevalence of ASCVD | T2DM Patients | Non-T2DM Patients |
p Value (vs. Non-T2DM) |
|---|---|---|---|
| Total ASCVD | 55.3% | 23.3% | <0.05 |
| Premature total ASCVD | 48.8% | 20.0% | <0.05 |
| CAD | 48.8% | 20.7% | <0.05 |
| MI | 39.0% | 15.3% | <0.05 |
| Premature CAD | 43.9% | 18.5% | <0.05 |
| Stroke | 8.9% | 2.7% | <0.05 |
| Premature stroke | 2.4% | 0.9% | <0.05 |
| PAD | 7.3% | 2.3% | <0.05 |
| Premature PAD | 2.4% | 0.9% | NS |
T2DM: Type 2 diabetes mellitus; ASCVD: atherosclerotic cardiovascular disease; CAD: coronary artery disease; MI: myocardial infarction; PAD: peripheral arterial disease; NS: non-significant.